NCLEXpharmacologymediumQRN-NCLEX-00721694A9

A client is receiving Trimetrexate for treatment of a malignancy. After reviewing the client's chart, the physician orders Wellcovorin (leucovorin calcium). What is the rationale for administering leucovorin calcium to a client receiving trimetrexate?

A.To treat iron-deficiency anemia caused by chemotherapeutic agentsB.To create a synergistic effect that shortens the length of treatmentC.To increase the number of circulating neutrophilsD.To reverse drug toxicity and prevent tissue damage

Report question Practice more NCLEX

A client is receiving Trimetrexate for treatment of a malignancy. After reviewing the client's chart, the physician orders Wellcovorin (leucovorin calcium). What is the rationale for administering leucovorin calcium to a client receiving trimetrexate?

Related questions